OrthoPediatrics Corp.
DE ˙ DB ˙ US68752L1008
€ 15,50 ↑1.50 (10.71%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:2X7 / OrthoPediatrics Corp.
InstitutionVanguard Group Inc
Latest Disclosed Ownership970,445 shares
Latest Disclosed Value $ 17,235,104
Vanguard Group Inc reports 0.95% increase in ownership of 2X7 / OrthoPediatrics Corp.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 970,445 shares of OrthoPediatrics Corp. (DE:2X7) valued at $14,362,586 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 961,330 shares of OrthoPediatrics Corp.. This represents a change in shares of 0.95% during the quarter. The current value of the position is $15,041,898 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ORTHOPEDIATRICS COM 68752L100 970,445 9,115 0.95 17,235 -3.24 0.0002
2025-11-07 2025-09-30 13F ORTHOPEDIATRICS COM 68752L100 961,330 10,927 1.15 17,813 -12.74 0.0003
2025-08-11 2025-06-30 13F ORTHOPEDIATRICS COM 68752L100 950,403 12,434 1.33 20,415 -11.64 0.0003
2025-05-09 2025-03-31 13F ORTHOPEDIATRICS COM 68752L100 937,969 14,079 1.52 23,102 7.88 0.0004
2025-02-11 2024-12-31 13F ORTHOPEDIATRICS COM 68752L100 923,890 -32,165 -3.36 21,416 -17.37 0.0004
2024-11-13 2024-09-30 13F ORTHOPEDIATRICS COM 68752L100 956,055 47,474 5.23 25,919 -0.81 0.0005
2024-08-13 2024-06-30 13F ORTHOPEDIATRICS COM 68752L100 908,581 24,754 2.80 26,131 1.39 0.0005
2024-05-10 2024-03-31 13F ORTHOPEDIATRICS COM 68752L100 883,827 11,100 1.27 25,772 -9.16 0.0005
2024-03-11 2023-12-31 13F/A-1 ORTHOPEDIATRICS COM 68752L100 872,727 11,923 1.39 28,372 3.00 0.0006
2024-02-14 2023-12-31 13F ORTHOPEDIATRICS COM 68752L100 872,727 11,923 28,372 0.0005
2023-12-18 2023-09-30 13F/A-1 ORTHOPEDIATRICS COM 68752L100 860,804 10,861 1.28 27,546 -26.09 0.0007
2023-11-14 2023-09-30 13F ORTHOPEDIATRICS COM 68752L100 860,804 10,861 27,546 0.0001
2023-08-14 2023-06-30 13F ORTHOPEDIATRICS COM 68752L100 849,943 13,263 1.59 37,270 0.58 0.0009
2023-07-14 2023-03-31 13F/A-1 ORTHOPEDIATRICS COM 68752L100 836,680 39,798 4.99 37,057 17.04 0.0009
2023-05-15 2023-03-31 13F ORTHOPEDIATRICS COM 68752L100 836,680 39,798 37,057 0.0002
2023-02-10 2022-12-31 13F ORTHOPEDIATRICS COM 68752L100 796,882 8,351 1.06 31,660 -12.98 0.0009
2022-11-14 2022-09-30 13F ORTHOPEDIATRICS COM 68752L100 788,531 30,333 4.00 36,383 11.21 0.0011
2022-08-12 2022-06-30 13F ORTHOPEDIATRICS COM 68752L100 758,198 32,015 4.41 32,716 -16.56 0.0009
2022-05-13 2022-03-31 13F ORTHOPEDIATRICS COM 68752L100 726,183 -6,182 -0.84 39,207 -10.57 0.0009
2022-02-14 2021-12-31 13F ORTHOPEDIATRICS COM 68752L100 732,365 2,761 0.38 43,840 -8.28 0.0010
2021-11-12 2021-09-30 13F ORTHOPEDIATRICS COM 68752L100 729,604 -1,012 -0.14 47,796 3.54 0.0012
2021-08-13 2021-06-30 13F ORTHOPEDIATRICS COM 68752L100 730,616 23,764 3.36 46,161 33.96 0.0011
2021-05-14 2021-03-31 13F ORTHOPEDIATRICS COM 68752L100 706,852 16,831 2.44 34,459 21.06 0.0009
2021-02-12 2020-12-31 13F ORTHOPEDIATRICS COM 68752L100 690,021 48,640 7.58 28,464 -3.35 0.0008
2020-11-16 2020-09-30 13F ORTHOPEDIATRICS COM 68752L100 641,381 -15,591 -2.37 29,452 2.45 0.0010
2020-08-14 2020-06-30 13F ORTHOPEDIATRICS COM 68752L100 656,972 103,837 18.77 28,749 31.12 0.0010
2020-05-15 2020-03-31 13F ORTHOPEDIATRICS COM 68752L100 553,135 22,812 4.30 21,926 -12.01 0.0009
2020-02-14 2019-12-31 13F ORTHOPEDIATRICS COM 68752L100 530,323 65,139 14.00 24,920 51.93 0.0008
2019-11-14 2019-09-30 13F ORTHOPEDIATRICS COM 68752L100 465,184 7,538 1.65 16,402 -8.10 0.0006
2019-08-14 2019-06-30 13F ORTHOPEDIATRICS COM 68752L100 457,646 20,799 4.76 17,848 -7.63 0.0007
2019-05-15 2019-03-31 13F ORTHOPEDIATRICS COM 68752L100 436,847 15,262 3.62 19,322 31.40 0.0008
2019-02-14 2018-12-31 13F ORTHOPEDIATRICS COM 68752L100 421,585 102,032 31.93 14,705 25.60 0.0007
2018-12-13 2018-09-30 13F/A-2 ORTHOPEDIATRICS COM 68752L100 319,553 28,073 9.63 11,708 50.78 0.0005
2018-11-23 2018-09-30 13F/A-1 ORTHOPEDIATRICS COM 68752L100 319,553 0 11,708 0.0005
2018-11-14 2018-09-30 13F ORTHOPEDIATRICS COM 68752L100 319,553 28,073 11,708
2018-08-14 2018-06-30 13F ORTHOPEDIATRICS COM 68752L100 291,480 119,100 69.09 7,765 199.11 0.0003
2018-05-15 2018-03-31 13F ORTHOPEDIATRICS COM 68752L100 172,380 34,537 25.06 2,596 -1.85 0.0001
2018-02-14 2017-12-31 13F ORTHOPEDIATRICS COM 68752L100 137,843 137,843 2,645 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.